Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ildiko Van Rhijn, Ph.D.

Co-Author

This page shows the publications co-authored by Ildiko Van Rhijn and Megan Murray.
Connection Strength

1.118
  1. Dual TCR-a Expression on Mucosal-Associated Invariant T Cells as a Potential Confounder of TCR Interpretation. J Immunol. 2022 Mar 15; 208(6):1389-1395.
    View in: PubMed
    Score: 0.248
  2. Synthetic mycobacterial diacyl trehaloses reveal differential recognition by human T cell receptors and the C-type lectin Mincle. Sci Rep. 2021 01 21; 11(1):2010.
    View in: PubMed
    Score: 0.229
  3. CD1b Tetramers Broadly Detect T Cells That Correlate With Mycobacterial Exposure but Not Tuberculosis Disease State. Front Immunol. 2020; 11:199.
    View in: PubMed
    Score: 0.215
  4. A TCR ß-Chain Motif Biases toward Recognition of Human CD1 Proteins. J Immunol. 2019 12 15; 203(12):3395-3406.
    View in: PubMed
    Score: 0.211
  5. Multimodally profiling memory T cells from a tuberculosis cohort identifies cell state associations with demographics, environment and disease. Nat Immunol. 2021 06; 22(6):781-793.
    View in: PubMed
    Score: 0.059
  6. Peripheral Blood Mucosal-Associated Invariant T Cells in Tuberculosis Patients and Healthy Mycobacterium tuberculosis-Exposed Controls. J Infect Dis. 2020 08 17; 222(6):995-1007.
    View in: PubMed
    Score: 0.056
  7. RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response. Sci Rep. 2020 05 25; 10(1):8629.
    View in: PubMed
    Score: 0.055
  8. T cell autoreactivity directed toward CD1c itself rather than toward carried self lipids. Nat Immunol. 2018 04; 19(4):397-406.
    View in: PubMed
    Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.